Heart Test Laboratories, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-1 effective as of March 13, 2024, at 4:00 P.M. The Form S-1 is a registration statement that companies must file with the SEC before they can proceed with an initial public offering (IPO) of their securities. The effectiveness of this form indicates that Heart Test Laboratories has met all the regulatory requirements set forth by the SEC, clearing a crucial step in the process of offering its shares to the public.

Heart Test Laboratories, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-1 effective as of March 13, 2024, at 4:00 P.M. The Form S-1 is a registration statement that companies must file with the SEC before they can proceed with an initial public offering (IPO) of their securities. The effectiveness of this form indicates that Heart Test Laboratories has met all the regulatory requirements set forth by the SEC, clearing a crucial step in the process of offering its shares to the public.